Digestive Diseases and Sciences

, Volume 55, Issue 2, pp 535–536 | Cite as

Bismuth Salts in the Treatment of Helicobacter pylori Infection in Children

  • Selim Gökçe


Bismuth Positive Predictive Value Pylorus Infection Clarithromycin Triple Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Dehghani SH, Erjaee A, Imanieh MH, Haghighat M. Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children. Dig Dis Sci. 2009;54:1720–1724.CrossRefPubMedGoogle Scholar
  2. 2.
    Kindermann A, Demmelmair H, Koletzko B, Krauss-Etschmann S, Wiebecke B, Koletzko S. Influence of age on 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr. 2000;30:85–91.CrossRefPubMedGoogle Scholar
  3. 3.
    Jang HR, Seo JK. Diagnostic accuracy of the 13C urea breath test in children: adjustment of the cut-off value according to age. J Gastroenterol Hepatol. 2005;20:264–269.CrossRefGoogle Scholar
  4. 4.
    Nijevitch AA, Sataev VU, Akhmadeyeva EN, Arsamastsev AG. Nifuratel-containing initial anti-Helicobacter pylori triple therapy in children. Helicobacter. 2007;12:132–135.CrossRefPubMedGoogle Scholar
  5. 5.
    Bahremand S, Nematollahi LR, Fourutan H, et al. Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial. Eur J Gastroenterol Hepatol. 2006;18:511–514.CrossRefPubMedGoogle Scholar
  6. 6.
    Usta Y, Saltik-Temizel IN, Uslu N, Ozen H, Gurakan F, Yuce A. Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection. J Gastroenterol. 2008;43(6):429–433.CrossRefPubMedGoogle Scholar
  7. 7.
    Shamaly H, Berkowitz D, Rosenthal E, Naveh Y. Efficacy of bismuth-based triple therapy in children with abdominal pain and Helicobacter pylori gastritis. J Pediatr Gastroenterol Nutr. 2000;30:198–200.CrossRefPubMedGoogle Scholar
  8. 8.
    Oderda G, Shcherbakov P, Bontems P, et al. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter. 2007;12:150–156.CrossRefPubMedGoogle Scholar
  9. 9.
    Saad RJ, Schoenfeld P, Kim HM, Chey WD. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a metaanalysis. Am J Gastroenterol. 2006;101:488–496.CrossRefPubMedGoogle Scholar
  10. 10.
    Gisbert JP, Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther. 2006;23:35–44.CrossRefPubMedGoogle Scholar
  11. 11.
    Vaira D, Ricci C, Lanzini A, Perna F, Romano A, Corinaldesi R. How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy. Dig Dis. 2007;25:203–205.CrossRefPubMedGoogle Scholar
  12. 12.
    Fujimara S, Kato S, Linuma K, Watanebe A. In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children. J Med Microbiol. 2004;53:1019–1022.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Pediatric Gastroenterology, Hepatology and NutritionDr. Sami Ulus Children’s HospitalAnkaraTurkey

Personalised recommendations